Researchers from the University of Illinois at Chicago College of Medicine have identified a unique chemical biomarker associated with epileptic brain tissue, according to an article published in the journal Epilepsia.
The chemical signature can be detected noninvasively and could enable physicians to precisely locate small regions of abnormal brain tissue in early-stage patients. The researchers also suggested that the biomarker could be used to pin-point localized regions of the brain needed for therapeutic removal.
Get the full story at our sister site, Drug Delivery Business News.